Erythrocyte glycolysis in severe obstructive sleep apnea (OSA)

P. Panagou, G. Papatheodorou, M. Karaiskou, S. Tsipra, C. Mermingis, K. Psathakis, K. Tsintiris (Athens, Greece)

Source: Annual Congress 2005 - Systemic effects of OSA
Session: Systemic effects of OSA
Session type: Thematic Poster Session
Number: 2301
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Panagou, G. Papatheodorou, M. Karaiskou, S. Tsipra, C. Mermingis, K. Psathakis, K. Tsintiris (Athens, Greece). Erythrocyte glycolysis in severe obstructive sleep apnea (OSA). Eur Respir J 2005; 26: Suppl. 49, 2301

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Erythrocyte production in obstructive sleep apnea
Source: Eur Respir J 2004; 24: Suppl. 48, 692s
Year: 2004

Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002

Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Predictors of hypercapnia in obstructive sleep apnoea (OSA)
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Hyperuricaemia in females with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2003; 22: Suppl. 45, 91s
Year: 2003

Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 418s
Year: 2006

Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002

Hyperuricaemia in males with obstructive sleep apnoea (OSA)
Source: Eur Respir J 2001; 18: Suppl. 33, 334s
Year: 2001

Catecholamine secretion in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005

Prevalence of nocturia in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 646s
Year: 2006

Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005

Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004

Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007

Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Screening for obstructive sleep apnea (OSA) in acromegaly
Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea
Year: 2020


Masked hypertension and obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 416s
Year: 2006